- Home
- CRIS vs PCLA Comparison
CRIS vs PCLA Comparison
Compare CRIS & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- PCLA
- Stock Information
- Founded
- CRIS 2000
- PCLA 2008
- Country
- CRIS United States
- PCLA Japan
- Employees
- CRIS N/A
- PCLA N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- PCLA Building Products
- Sector
- CRIS Health Care
- PCLA Consumer Discretionary
- Exchange
- CRIS Nasdaq
- PCLA Nasdaq
- Market Cap
- CRIS 22.9M
- PCLA 18.6M
- IPO Year
- CRIS 2000
- PCLA 2025
- Fundamental
- Price
- CRIS $1.67
- PCLA $0.50
- Analyst Decision
- CRIS Strong Buy
- PCLA
- Analyst Count
- CRIS 2
- PCLA 0
- Target Price
- CRIS $16.50
- PCLA N/A
- AVG Volume (30 Days)
- CRIS 76.7K
- PCLA 199.5K
- Earning Date
- CRIS 11-13-2025
- PCLA 01-01-0001
- Dividend Yield
- CRIS N/A
- PCLA N/A
- EPS Growth
- CRIS N/A
- PCLA N/A
- EPS
- CRIS N/A
- PCLA N/A
- Revenue
- CRIS $11,405,000.00
- PCLA $5,475,228.00
- Revenue This Year
- CRIS $1.41
- PCLA N/A
- Revenue Next Year
- CRIS $7.46
- PCLA N/A
- P/E Ratio
- CRIS N/A
- PCLA N/A
- Revenue Growth
- CRIS 12.24
- PCLA 40.19
- 52 Week Low
- CRIS $1.02
- PCLA $0.37
- 52 Week High
- CRIS $6.44
- PCLA $9.80
- Technical
- Relative Strength Index (RSI)
- CRIS 45.61
- PCLA 46.55
- Support Level
- CRIS $1.63
- PCLA $0.42
- Resistance Level
- CRIS $1.95
- PCLA $0.55
- Average True Range (ATR)
- CRIS 0.15
- PCLA 0.04
- MACD
- CRIS 0.00
- PCLA 0.02
- Stochastic Oscillator
- CRIS 17.65
- PCLA 63.36
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.